New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 19, 2014
08:13 EDTADHD, JPMAlcobra appoints Dr. Tomer Berkovitz as CFO
Alcobra (ADHD) announced that it has appointed Dr. Tomer Berkovitz as CFO, effective May 1. Alcobra also announced that effective May 1, Mr. Udi Gilboa will step down as Acting CFO to pursue other interests. Gilboa will continue to serve as a director of Alcobra. Dr. Berkovitz joins Alcobra after six years at J.P. Morgan (JPM), most recently as an executive director in its corporate finance advisory group.
News For ADHD;JPM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
June 29, 2015
07:45 EDTJPMJPMorgan downgraded to Perform from Outperform at Oppenheimer
Oppenheimer downgraded JPMorgan based on valuation.
June 25, 2015
07:16 EDTJPMJPMorgan executive Patrick Moore leaves company, Reuters reports
Subscribe for More Information
07:13 EDTJPMFed director says full transparency in stress testing can be 'enormous weakness'
Subscribe for More Information
06:03 EDTJPMJPMorgan in settlement talks with SEC to settle product steering probe, WSJ says
Subscribe for More Information
June 24, 2015
12:30 EDTADHDOn The Fly: Top stock stories at midday
Subscribe for More Information
10:03 EDTADHDHigh option volume stocks: VNDA SN ADHD UNIS
10:00 EDTADHDOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Autoliv (ALV) downgraded to Sell from Neutral at Goldman... Catamaran (CTRX) downgraded to Neutral from Buy at UBS... Citi (C) downgraded to Hold from Buy at Deutsche Bank... Esperion (ESPR) downgraded to Neutral from Outperform at Credit Suisse... Fortinet (FTNT) downgraded to Neutral from Buy at Citi... General Motors (GM) downgraded to Neutral from Buy at Goldman... Goldman Sachs (GS) downgraded to Hold from Buy at Deutsche Bank... IBERIABANK (IBKC) downgraded to Neutral from Outperform at Baird... Independent Bank (INDB) downgraded to Underperform from Neutral at Baird... Inphi (IPHI) downgraded to Market Perform from Outperform at Northland... MoneyGram (MGI) downgraded to Neutral from Outperform at Macquarie... Sensata (ST) downgraded to Hold from Buy at Cross Research... Teradyne (TER) downgraded to Buy from Conviction Buy at Goldman... Alcobra (ADHD) downgraded to Hold from Speculative Buy at WBB Securities.
09:25 EDTADHDAlcobra downgraded to Hold from Speculative Buy at WBB Securities
Subscribe for More Information
09:10 EDTADHDOn The Fly: Pre-market Movers
Subscribe for More Information
08:57 EDTJPMJPMorgan price target raised to $77 from $70 at Argus
Argus increased its price target on JPMorgan based on the bank's cost cutting efforts and expectations for rising interest rates., along with what Argus sees as moderating concerns over litigation expenses and a good investment banking/trading environment. The firm expects the stock's multiple to increase, and it reiterates a Buy rating.
07:45 EDTADHDAlcobra to hold a conference call
Subscribe for More Information
07:19 EDTJPMJPMorgan names Nachimowski head of chemicals dealmaking in EMEA, Bloomberg says
Subscribe for More Information
06:37 EDTJPMDeutsche downgrades Citi, Goldman after share rallies
Deutsche Bank analyst Matt O'Connor recommends using the strong share performance of both Citi (C) and Goldman Sachs (GS) as on opportunity to take profits. The analyst this morning downgraded shares of both investment banks to Hold from Buy. Citi is up 21% from the lows on January 30 while Goldman is up 30% since July 1, 2014, the analyst points out. On Citi, O'Connor sees less near term upside with fixed income trading entering a seasonally weak period and core cost reductions largely over. On Goldman, the analyst sees a lack of catalysts to drive the stock meaningfully higher in the near term. His top picks among U.S. Banks are Bank of America (BAC), JPMorgan (JPM), M&T Bank (MTB) and SunTrust (STI).
06:04 EDTADHDAlcobra's MDX did not meet ADHD endpoint in Phase 2 trial
Subscribe for More Information
June 23, 2015
19:03 EDTADHDOn The Fly: After Hours Movers
UP AFTER PROVIDING GUIDANCE: MeetMe (MEET), up 18.8%. ALSO HIGHER: Nektar Therapeutics (NKTR), up 4.3% after being added to S&P 600... Quidel (QDEL), up 5% after receiving FDA clearance for new Solana molecular system and assay... Vanda Pharmaceuticals (VNDA), up 4.6% after announcing positive results from REPRIEVE study... Netflix (NFLX), up 3.4% after announcing seven-for-one stock split. LOWER: Alcobra (ADHD), down 2.5% after announcing that it will host a conference call and simultaneous webcast presentation to present results from the Phase II clinical trial of MDX... Sysco (SYY), down 2.6% after bid for U.S. foods blocked was blocked by a federal judge... Boeing (BA), down marginally after announcing CEO transition.
17:43 EDTADHDAlcobra to present results from the Phase II clinical trial of MDX
Subscribe for More Information
June 22, 2015
16:00 EDTJPMOptions Update; June 22, 2015
iPath S&P 500 VIX Short-Term Futures down 78c to 17.45. Option volume leaders: AAPL FB BAC CHK WMB BABA TWTR MU AMBA TSLA JPM
June 17, 2015
14:55 EDTJPMJPMorgan announces unexpected death of Vice Chairman Jimmy Lee
Subscribe for More Information
11:16 EDTJPMOCC restricts some banks from certain mortgage related business activity
Subscribe for More Information
06:48 EDTJPMMore big banks waiving overdraft fees, WSJ reports
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use